0000950170-24-043432.txt : 20240410 0000950170-24-043432.hdr.sgml : 20240410 20240410171933 ACCESSION NUMBER: 0000950170-24-043432 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240408 FILED AS OF DATE: 20240410 DATE AS OF CHANGE: 20240410 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Khayal Tamer I CENTRAL INDEX KEY: 0001430462 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38891 FILM NUMBER: 24836648 MAIL ADDRESS: STREET 1: TRANSMEDICS INC STREET 2: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TransMedics Group, Inc. CENTRAL INDEX KEY: 0001756262 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 BUSINESS PHONE: 9785520900 MAIL ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 4 1 ownership.xml 4 X0508 4 2024-04-08 0001756262 TransMedics Group, Inc. TMDX 0001430462 Khayal Tamer I C/O TRANSMEDICS GROUP, INC. 200 MINUTEMAN ROAD ANDOVER MA 01810 false true false false Chief Commercial Officer true Common Stock 2024-04-08 4 M false 4388 16.14 A 29573 D Common Stock 2024-04-08 4 S false 4388 90.00 D 25185 D Common Stock 2024-04-09 4 M false 8341 16.14 A 33526 D Common Stock 2024-04-09 4 M false 7171 38.46 A 40697 D Common Stock 2024-04-09 4 S false 10532 90.14 D 30165 D Common Stock 2024-04-09 4 S false 4980 91.11 D 25185 D Common Stock 14776 I By the Khayal Family 2021 Irrevocable Trust Common Stock 11051 I By the Tamer Ibrahim Ahmed Khayal Trust Stock Option (Right to Buy) 16.14 2024-04-08 4 M false 4388 0.00 D 2030-02-27 Common Stock 4388 8341 D Stock Option (Right to Buy) 16.14 2024-04-09 4 M false 8341 0.00 D 2030-02-27 Common Stock 8341 0 D Stock Option (Right to Buy) 38.46 2024-04-09 4 M false 7171 0.00 D 2031-02-24 Common Stock 7171 61368 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.025, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $91.00 to $91.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The option is fully vested. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. By: /s/ Stephen Gordon, Attorney-in-Fact 2024-04-10